000306343 001__ 306343
000306343 005__ 20251122115852.0
000306343 0247_ $$2doi$$a10.1093/neuonc/noaf237
000306343 0247_ $$2pmid$$apmid:41259653
000306343 0247_ $$2ISSN$$a1522-8517
000306343 0247_ $$2ISSN$$a1523-5866
000306343 037__ $$aDKFZ-2025-02559
000306343 041__ $$aEnglish
000306343 082__ $$a610
000306343 1001_ $$aLandry, Alexander P$$b0
000306343 245__ $$aA framework for using DNA methylation-based modelling for the clinical management of cranial meningioma.
000306343 260__ $$aOxford$$bOxford Univ. Press$$c2025
000306343 3367_ $$2DRIVER$$aarticle
000306343 3367_ $$2DataCite$$aOutput Types/Journal article
000306343 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1763732918_2665072
000306343 3367_ $$2BibTeX$$aARTICLE
000306343 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000306343 3367_ $$00$$2EndNote$$aJournal Article
000306343 500__ $$aepub
000306343 520__ $$aDNA methylation profiling can be used to robustly predict postsurgical outcomes and response to radiotherapy (RT) for meningioma patients. To allow for seamless integration of these complementary models into clinical practice, a practical framework is needed.We leveraged a cohort of nearly 2000 surgically-treated meningiomas with DNA methylation profiling and clinical outcomes data. Existing methylation-based prediction models were dichotomized to yield four risk groups: low and high recurrent risk, each with RT sensitive and resistant subgroups. Risk groups were correlated with progression-free survival in the context of existing biomarkers including extent of resection and WHO grade.We first demonstrated that all risk groups benefit from gross total resection. All 'high-risk, RT sensitive' tumors (n = 306, 15.7%) also benefited from adjuvant RT: after GTR, median PFS increased from 4.68 (4.13-9.48) years to not reached (p = 0.003); after STR, from 2.12 (1.59-3.02) to 4.09 (3.41-not reached) years (p = 0.004). 'Low-risk, RT sensitive cases' (n = 1207, 61.8%) also benefitted from RT after STR (median PFS 7.39 (6.66-12.8) vs. 16.53 (10.35-not reached) years, p = 0.03), suggesting that RT be considered in these patients. Neither 'low-risk RT resistant' (n = 84, 4.3%) nor 'high-risk RT resistant' (n = 356, 18.2%) cases benefitted from RT, and the latter group was associated with universally poor outcomes.We identify methylation-defined risk groups of meningioma for which additional benefit is gained from adjuvant RT, leading to a clinical decision-making framework for straightforward integration of molecular models into clinical practice.
000306343 536__ $$0G:(DE-HGF)POF4-312$$a312 - Funktionelle und strukturelle Genomforschung (POF4-312)$$cPOF4-312$$fPOF IV$$x0
000306343 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000306343 650_7 $$2Other$$aDNA methylation
000306343 650_7 $$2Other$$aMeningioma
000306343 650_7 $$2Other$$aclinical recommendations
000306343 650_7 $$2Other$$aneuro-oncology
000306343 650_7 $$2Other$$aoutcome biomarker
000306343 7001_ $$aWang, Justin Z$$b1
000306343 7001_ $$aPatil, Vikas$$b2
000306343 7001_ $$aAjisebutu, Andrew$$b3
000306343 7001_ $$aGui, Chloe$$b4
000306343 7001_ $$aYefet, Leeor S$$b5
000306343 7001_ $$aEllenbogen, Yosef$$b6
000306343 7001_ $$aLiu, Jeff$$b7
000306343 7001_ $$aMamatjan, Yasin$$b8
000306343 7001_ $$aWei, Qingxia$$b9
000306343 7001_ $$aSingh, Olivia$$b10
000306343 7001_ $$aMansouri, Sheila$$b11
000306343 7001_ $$aEhret, Felix$$b12
000306343 7001_ $$0P:(DE-He78)51bf9ae9cb5771b30c483e5597ef606c$$aCapper, David$$b13$$udkfz
000306343 7001_ $$aCohen-Gadol, Aaron A$$b14
000306343 7001_ $$0P:(DE-He78)d53ff17be4b468909d803eccd92df3d6$$aTabatabai, Ghazaleh$$b15$$udkfz
000306343 7001_ $$aTatagiba, Marcos$$b16
000306343 7001_ $$aBehling, Felix$$b17
000306343 7001_ $$aBarnholtz-Sloan, Jill S$$b18
000306343 7001_ $$aSloan, Andrew E$$b19
000306343 7001_ $$aChambless, Lola B$$b20
000306343 7001_ $$aMansouri, Alireza$$b21
000306343 7001_ $$aMakarenko, Serge$$b22
000306343 7001_ $$aYip, Stephen$$b23
000306343 7001_ $$aTsang, Derek S$$b24
000306343 7001_ $$aGao, Andrew$$b25
000306343 7001_ $$aMeningiomas, International Consortium On$$b26$$eCollaboration Author
000306343 7001_ $$aAldape, Kenneth$$b27
000306343 7001_ $$aNassiri, Farshad$$b28
000306343 7001_ $$aZadeh, Gelareh$$b29
000306343 7001_ $$aSantarius, Thomas$$b30$$eContributor
000306343 7001_ $$aSelman, Warren$$b31$$eContributor
000306343 7001_ $$aCouce, Marta$$b32$$eContributor
000306343 7001_ $$aSloan, Andrew E$$b33$$eContributor
000306343 7001_ $$aBrastianos, Priscilla K$$b34$$eContributor
000306343 7001_ $$aShih, Helen A$$b35$$eContributor
000306343 7001_ $$aBi, W Linda$$b36$$eContributor
000306343 7001_ $$aHuang, Raymond Y$$b37$$eContributor
000306343 7001_ $$aWen, Patrick Y$$b38$$eContributor
000306343 7001_ $$aWalbert, Tobias$$b39$$eContributor
000306343 7001_ $$aLee, Ian$$b40$$eContributor
000306343 7001_ $$aFelicella, Michelle$$b41$$eContributor
000306343 7001_ $$aBrodie, Chaya$$b42$$eContributor
000306343 7001_ $$aMalta, Tathiane$$b43$$eContributor
000306343 7001_ $$aCastro, Ana Valeria C$$b44$$eContributor
000306343 7001_ $$aNoushmehr, Houtan$$b45$$eContributor
000306343 7001_ $$aSnyder, James$$b46$$eContributor
000306343 7001_ $$aDimeco, Francesco$$b47$$eContributor
000306343 7001_ $$aSaladino, Andrea$$b48$$eContributor
000306343 7001_ $$aPollo, Bianca$$b49$$eContributor
000306343 7001_ $$aSchichor, Christian$$b50$$eContributor
000306343 7001_ $$aTonn, Jorg-Christian$$b51$$eContributor
000306343 7001_ $$aKaufmann, Timothy J$$b52$$eContributor
000306343 7001_ $$aLachance, Daniel$$b53$$eContributor
000306343 7001_ $$aGiannini, Caterina$$b54$$eContributor
000306343 7001_ $$aGalanis, Evanthia$$b55$$eContributor
000306343 7001_ $$aRaghunathan, Aditya$$b56$$eContributor
000306343 7001_ $$aHanemann, C Oliver$$b57$$eContributor
000306343 7001_ $$aAu, Karolyn$$b58$$eContributor
000306343 7001_ $$aGoldbrunner, Roland$$b59$$eContributor
000306343 7001_ $$aGalldiks, Norbert$$b60$$eContributor
000306343 7001_ $$aTimmer, Marco$$b61$$eContributor
000306343 7001_ $$aSchimdt, Nils Ole$$b62$$eContributor
000306343 7001_ $$aHerold-Mende, Christel$$b63$$eContributor
000306343 7001_ $$0P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88$$aSahm, Felix$$b64$$eContributor$$udkfz
000306343 7001_ $$aJungk, Christine$$b65$$eContributor
000306343 7001_ $$aJungwirth, Gerhard$$b66$$eContributor
000306343 7001_ $$0P:(DE-He78)a8a10626a848d31e70cfd96a133cc144$$aVon Deimling, Andreas$$b67$$eContributor$$udkfz
000306343 7001_ $$aJenkinson, Michael D$$b68$$eContributor
000306343 7001_ $$aMillward, Christopher P$$b69$$eContributor
000306343 7001_ $$aIslim, Abdurrahman I$$b70$$eContributor
000306343 7001_ $$aDrummond, Katharine$$b71$$eContributor
000306343 7001_ $$aMorokoff, Andrew$$b72$$eContributor
000306343 7001_ $$0P:(DE-He78)d53ff17be4b468909d803eccd92df3d6$$aTabatabai, Ghazaleh$$b73$$eContributor$$udkfz
000306343 7001_ $$aBehling, Felix$$b74$$eContributor
000306343 7001_ $$aRenovanz, Mirjam$$b75$$eContributor
000306343 7001_ $$aTatagiba, Marcos$$b76$$eContributor
000306343 7001_ $$aSantacroce, Antonio$$b77$$eContributor
000306343 7001_ $$aFougere, Christian la$$b78$$eContributor
000306343 7001_ $$aSchittenhelm, Jens$$b79$$eContributor
000306343 7001_ $$aRaleigh, David R$$b80$$eContributor
000306343 7001_ $$aPerry, Arie$$b81$$eContributor
000306343 7001_ $$aButowski, Nicholas$$b82$$eContributor
000306343 7001_ $$aWestphal, Manfred$$b83$$eContributor
000306343 7001_ $$aLamszus, Katrin$$b84$$eContributor
000306343 7001_ $$aRicklefs, Franz$$b85$$eContributor
000306343 7001_ $$aMawrin, Christian$$b86$$eContributor
000306343 7001_ $$aHorbinski, Craig M$$b87$$eContributor
000306343 7001_ $$aNg, Ho-Keung$$b88$$eContributor
000306343 7001_ $$aSnuderl, Matija$$b89$$eContributor
000306343 7001_ $$aKurz, Sylvia$$b90$$eContributor
000306343 7001_ $$aSulman, Erik P$$b91$$eContributor
000306343 7001_ $$aZada, Gabriel$$b92$$eContributor
000306343 7001_ $$aCohen-Gadol, Aaron$$b93$$eContributor
000306343 7001_ $$aYip, Stephen$$b94$$eContributor
000306343 7001_ $$aMakarenko, Serge$$b95$$eContributor
000306343 7001_ $$aZherebitskiy, Viktor$$b96$$eContributor
000306343 7001_ $$aHnenny, Luke$$b97$$eContributor
000306343 7001_ $$aDunn, Ian F$$b98$$eContributor
000306343 7001_ $$aMoliterno, Jennifer$$b99$$eContributor
000306343 7001_ $$aMcDermott, Michael W$$b100$$eContributor
000306343 7001_ $$aVogelbaum, Michael$$b101$$eContributor
000306343 7001_ $$aJavadpour, Mohsen$$b102$$eContributor
000306343 7001_ $$aFountain, Daniel$$b103$$eContributor
000306343 7001_ $$aMathiesen, Tiit Illimar$$b104$$eContributor
000306343 7001_ $$aAldape, Kenneth$$b105$$eContributor
000306343 7001_ $$aBarnholtz-Sloan, Jill$$b106$$eContributor
000306343 7001_ $$aPathmanaban, Omar$$b107$$eContributor
000306343 7001_ $$aBoutros, Paul C$$b108$$eContributor
000306343 7001_ $$aAlkividias, Tzannis$$b109$$eContributor
000306343 7001_ $$aFountas, Konstantinos N$$b110$$eContributor
000306343 7001_ $$aWalsh, Kyle M$$b111$$eContributor
000306343 7001_ $$aShort, Susan C$$b112$$eContributor
000306343 7001_ $$aCarvalho, Bruno$$b113$$eContributor
000306343 7001_ $$aMaas, Sybren L N$$b114$$eContributor
000306343 7001_ $$aBos, Eelke M$$b115$$eContributor
000306343 7001_ $$aDincer, Alper$$b116$$eContributor
000306343 7001_ $$aKurz, Sylvia$$b117$$eContributor
000306343 7001_ $$aPasslack, Peter$$b118$$eContributor
000306343 7001_ $$aDeng, Maximilian$$b119$$eContributor
000306343 7001_ $$aEhrat, Felix$$b120$$eContributor
000306343 7001_ $$aMehta, Minesh P$$b121$$eContributor
000306343 7001_ $$aOdia, Yazmin$$b122$$eContributor
000306343 7001_ $$aEverson, Richard$$b123$$eContributor
000306343 7001_ $$aBalogun, James A$$b124$$eContributor
000306343 7001_ $$aLopez, Clara$$b125$$eContributor
000306343 7001_ $$aCalabrese, Evan$$b126$$eContributor
000306343 7001_ $$aKarschnia, Philipp$$b127$$eContributor
000306343 7001_ $$aTeske, Nico$$b128$$eContributor
000306343 7001_ $$aFariselli, Laura$$b129$$eContributor
000306343 7001_ $$aGreve, Tobias$$b130$$eContributor
000306343 7001_ $$aArvaniti, Christina$$b131$$eContributor
000306343 7001_ $$aBenjamin, Carolina$$b132$$eContributor
000306343 7001_ $$aIvan, Michael$$b133$$eContributor
000306343 7001_ $$aJackson, Christina$$b134$$eContributor
000306343 7001_ $$aJeyaretna, Sanjeeva$$b135$$eContributor
000306343 7001_ $$aScartoni, Daniele$$b136$$eContributor
000306343 7001_ $$aAmelio, Dante$$b137$$eContributor
000306343 7001_ $$aPalmer, Joshua$$b138$$eContributor
000306343 7001_ $$aIvanidze, Jana$$b139$$eContributor
000306343 7001_ $$aOstrom, Quinn$$b140$$eContributor
000306343 7001_ $$aKien, Duong Trung$$b141$$eContributor
000306343 7001_ $$aYoungblood, Mark$$b142$$eContributor
000306343 7001_ $$aMillareschavez, Miguel$$b143$$eContributor
000306343 7001_ $$aAlThgafi, Malak$$b144$$eContributor
000306343 7001_ $$aEmerson, Sam$$b145$$eContributor
000306343 7001_ $$aWeller, Michael$$b146$$eContributor
000306343 7001_ $$aLeRhun, Emilie$$b147$$eContributor
000306343 7001_ $$aMartínez-Pérez, Rafael$$b148$$eContributor
000306343 7001_ $$aSmee, Robert$$b149$$eContributor
000306343 7001_ $$aMukherjee, Raj$$b150$$eContributor
000306343 7001_ $$aCervio, Andres$$b151$$eContributor
000306343 7001_ $$aTurner, Clinton$$b152$$eContributor
000306343 7001_ $$aMuirhead, Will$$b153$$eContributor
000306343 7001_ $$aSuero, Eric$$b154$$eContributor
000306343 7001_ $$aJulius, Vitowanu$$b155$$eContributor
000306343 7001_ $$aChen, Jiawei$$b156$$eContributor
000306343 7001_ $$aKarmur, Brij$$b157$$eContributor
000306343 7001_ $$aMrugala, Maciej$$b158$$eContributor
000306343 7001_ $$aNeth, Brian$$b159$$eContributor
000306343 773__ $$0PERI:(DE-600)2094060-9$$a10.1093/neuonc/noaf237$$gp. noaf237$$pnn$$tNeuro-Oncology$$vnn$$x1522-8517$$y2025
000306343 909CO $$ooai:inrepo02.dkfz.de:306343$$pVDB
000306343 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)51bf9ae9cb5771b30c483e5597ef606c$$aDeutsches Krebsforschungszentrum$$b13$$kDKFZ
000306343 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d53ff17be4b468909d803eccd92df3d6$$aDeutsches Krebsforschungszentrum$$b15$$kDKFZ
000306343 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88$$aDeutsches Krebsforschungszentrum$$b64$$kDKFZ
000306343 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a8a10626a848d31e70cfd96a133cc144$$aDeutsches Krebsforschungszentrum$$b67$$kDKFZ
000306343 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d53ff17be4b468909d803eccd92df3d6$$aDeutsches Krebsforschungszentrum$$b73$$kDKFZ
000306343 9131_ $$0G:(DE-HGF)POF4-312$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunktionelle und strukturelle Genomforschung$$x0
000306343 9141_ $$y2025
000306343 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2024-12-11$$wger
000306343 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEURO-ONCOLOGY : 2022$$d2024-12-11
000306343 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-11
000306343 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-11
000306343 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-11
000306343 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-11
000306343 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-11
000306343 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-11
000306343 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-11
000306343 915__ $$0StatID:(DE-HGF)9915$$2StatID$$aIF >= 15$$bNEURO-ONCOLOGY : 2022$$d2024-12-11
000306343 9201_ $$0I:(DE-He78)BE01-20160331$$kBE01$$lDKTK Koordinierungsstelle Berlin$$x0
000306343 9201_ $$0I:(DE-He78)TU01-20160331$$kTU01$$lDKTK Koordinierungsstelle Tübingen$$x1
000306343 9201_ $$0I:(DE-He78)B300-20160331$$kB300$$lKKE Neuropathologie$$x2
000306343 980__ $$ajournal
000306343 980__ $$aVDB
000306343 980__ $$aI:(DE-He78)BE01-20160331
000306343 980__ $$aI:(DE-He78)TU01-20160331
000306343 980__ $$aI:(DE-He78)B300-20160331
000306343 980__ $$aUNRESTRICTED